Stock Events

Stock Events

Search...

Virtus LifeSci Biotech Products

$62.66

3

-$0.44-0.7% Monday 19:48

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares NASDAQ Biotechnology ETF, tracks a similar index of biotechnology and pharmaceutical companies, directly competing in the biotech ETF space.

SPDR S&P Biotech ETF, offers exposure to the biotechnology sector, similar to BBP, but with a broader focus including small-cap companies.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, competes by investing in firms across the biotech industry, similar to BBP's investment focus.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, targets biotech and genome companies, competing in the same niche as BBP.

VanEck Vectors Biotech ETF, focuses on biotech firms, directly competing with BBP in targeting biotechnology investments.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, invests in small- and mid-cap companies in the medical sector, similar to BBP's focus on innovative biotech firms.

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares, offers leveraged exposure to biotech sector, competing for similar investor interest as BBP.

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares, provides inverse leveraged exposure to the biotech sector, appealing to investors with opposite market views but still in the same sector.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF, focuses on genomics and biotechnology, competing in the same specialized investment area as BBP.

About

Miscellaneous

Investment Trusts/Mutual Funds

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

Show more...

CEO

Country

US

ISIN

US26923G2021

Listings